Correction: Acute kidney injury in patients treated with immune checkpoint inhibitors

Correction: Acute kidney injury in patients treated with immune checkpoint inhibitors

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-04-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/11/4/e003467corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acute kidney injury in patients treated with immune checkpoint inhibitors
by: Joe-Elie Salem, et al.
Published: (2021-10-01)

Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
by: Marije S Koks, et al.
Published: (2021-01-01)

Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy
by: Yu Yamamoto, et al.
Published: (2022-03-01)

Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes
by: Eitan Amir, et al.
Published: (2020-05-01)

Sarcoid-Like Reaction Presenting With Hypercalcemia and Acute Kidney Injury in a Patient Treated With BRAF/MEK and Checkpoint Inhibitors
by: Stefanie Worwa, et al.
Published: (2025-08-01)

Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors
by: Abdulrahman Alghabban, MD, et al.
Published: (2025-05-01)

Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort study
by: Vin-Cent Wu, et al.
Published: (2025-02-01)

WCN24-2239 Acute kidney injury and electrolyte abnormalities associated with immune checkpoint inhibitors in patients with solid tumours
by: Dina Nilasari, et al.
Published: (2024-04-01)

Acute Kidney Injury After the Concurrent Use of Checkpoint Inhibitors and Proton Pump Inhibitors
by: Helen I. Gandler, et al.
Published: (2024-02-01)

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas
by: Magdalena Witkowska, et al.
Published: (2018-01-01)

Onset and progression of atherosclerosis in patients with melanoma treated with immune checkpoint inhibitors
by: Ron H J Mathijssen, et al.
Published: (2025-04-01)

Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study
by: Ling Chen, et al.
Published: (2025-01-01)

Correction: Efficacy of immune checkpoint inhibitors for in-transit melanoma
Published: (2020-10-01)

Prognostic Value of Biomarkers in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy
by: Christopher Mann, MD, et al.
Published: (2025-09-01)

Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors
by: Charles Dolladille, et al.
Published: (2020-05-01)

Left ventricular global longitudinal strain in patients treated with immune checkpoint inhibitors
by: Ece Celebi Coskun, et al.
Published: (2024-12-01)

Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Xiaoqing Zhou, et al.
Published: (2025-05-01)

Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients
by: Koji Imoto, et al.
Published: (2019-01-01)

Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors
by: Ling Yang, et al.
Published: (2025-08-01)

Real-Life Management of Elevated Troponin Level in Patients Treated with Immune Checkpoint Inhibitors
by: Lior Zornitzki, MD, et al.
Published: (2025-08-01)

Prediction of Cardiac Arrhythmias in Cancer Patients Treated with Immune Checkpoint Inhibitors Using Electrocardiogram
by: Alper Coskun, et al.
Published: (2025-05-01)

Splenic volume as a predictor of survival in cancer patients treated with immune checkpoint inhibitors
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors
by: Chester Kao, et al.
Published: (2025-04-01)

Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?
by: Jürgen Braun, et al.
Published: (2024-11-01)

Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Published: (2022-03-01)

Immune-checkpoint inhibitor resistance in patients with cancer
by: Luis Cabezón-Gutiérrez, et al.
Published: (2025-05-01)

Negative Immune Checkpoint Inhibitors
by: Magda Drewniak-Świtalska, et al.
Published: (2025-05-01)

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors
by: Julie M. Shabto, et al.
Published: (2020-04-01)

Hyperglycemia in patients treated with immune checkpoint inhibitors: key clinical challenges and multidisciplinary consensus recommendations
by: Ngai Wah Cheung, et al.
Published: (2025-06-01)

Concomitant anticoagulants and the survival of cancer patients treated with immune checkpoint inhibitors: a meta-analysis
by: Jin Xiong, et al.
Published: (2025-08-01)

A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab
by: Chance H. Bloomer, et al.
Published: (2022-01-01)

First case report of immune checkpoint inhibitor therapy to treat secretory carcinoma
by: Xiangyang Yu, et al.
Published: (2025-07-01)

Colonic Lung Cancer Metastasis in Vedolizumab-Treated Immune Checkpoint Inhibitor Colitis
by: Sean S. Davis, et al.
Published: (2020-07-01)

Risk of Immune-Related Pancreatitis in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors: Systematic Assessment with Meta-Analysis
by: Qiang Su, et al.
Published: (2018-01-01)

Patterns of immune-related adverse events in patients treated with immune checkpoint inhibitors: a Brazilian real-world analysis
by: Maria Paula Furtado Santos, et al.
Published: (2022-12-01)

Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors
by: Yusuke Hamakawa, et al.
Published: (2025-01-01)

Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors
by: Hanna Saadani, et al.
Published: (2025-07-01)

Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors
by: Khoudia Diop, et al.
Published: (2025-04-01)

Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma
by: Longhao Zhang, et al.
Published: (2024-06-01)

Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
by: Dominik Bettinger, et al.
Published: (2020-10-01)